SCM
BSX icon

SCS Capital Management’s Boston Scientific BSX Stock Holding History

SCS Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,106
Closed -$201K – 472
2025
Q4 		$201K Sell
2,106
-107
-5% -$10.5K ﹤0.01% 478
2025
Q3 		$216K Buy
2,213
+17
+0.8% +$1.76K ﹤0.01% 485
2025
Q2 		$236K Sell
2,196
-277
-11% -$28K ﹤0.01% 497
2025
Q1 		$249K Buy
+2,473
New +$249K ﹤0.01% 459

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SCS Capital Management's BSX Position: Q1 2026 in Review

SCS Capital Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,106 shares — an estimated $201K sold.

SCS Capital Management first reported a position in BSX in Q1 2025 and held it in 4 quarters. The position peaked at $249K in Q1 2025. 1,683 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • SCS Capital Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • SCS Capital Management sold 2,106 Boston Scientific shares in Q1 2026, an estimated $201K.
  • SCS Capital Management first reported a position in Boston Scientific in Q1 2025 and held it in 4 quarters.
  • SCS Capital Management's Boston Scientific position peaked at $249K in Q1 2025.
  • 1,683 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on SCS Capital Management's 13F filing for Q1 2026, filed 11 May 2026.